{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T14:01:22Z","timestamp":1762783282151,"version":"3.44.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aimed to explore the association between the liver fibrosis-4 (FIB4) index and clinical events, specifically haemocompatibility-related adverse events (HRAEs), in patients who underwent left ventricular assist device (LVAD) implantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study involved patients who received LVADs for advanced heart failure (HF) treatment. FIB4 index was calculated both preoperatively and postoperatively, and its association with clinical events was examined, focusing on all-cause mortality and HRAEs, which included severe bleeding, cerebrovascular accidents, and intra-pump thrombosis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 224 patients with LVAD were analyzed. The value of FIB4 index was significantly decreased after LVAD implantation, and the postoperative FIB4 index was independently associated with composite events, including all-cause death and HRAEs after adjustment of cofounders. Next, we clarified the association between postoperative FIB4 index and clinical events after LVAD implantation. Patients were divided into 2 groups based on a postoperative FIB4 index threshold of 1.45. The high FIB4 group was associated an elevated risk of HRAEs (P\u2009=\u20090.0038), with no significant difference in survival curves between the groups. Additionally, the high FIB4 group showed elevated von Willebrand factor activity, while no significant differences were found in prothrombin time international normalized ratio variability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>FIB4 index, a liver fibrosis marker, serves as a valuable prognostic indicator for HRAEs in patients receiving LVAD support.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejcts\/ezaf291","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T17:05:16Z","timestamp":1756487116000},"source":"Crossref","is-referenced-by-count":4,"title":["Fibrosis 4 Index Predicts Haemocompatibility-Related Adverse Events in Patients Using Left Ventricular Assist Devices"],"prefix":"10.1093","volume":"67","author":[{"given":"Takahiro","family":"Kurihara","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2810-8040","authenticated-orcid":false,"given":"Eisuke","family":"Amiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]},{"name":"Department of Advanced Medical Center for Heart Failure, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Bujo","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Isotani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saki","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsura","family":"Soma","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Minatsuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5481-3782","authenticated-orcid":false,"given":"Masahiko","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo , Tokyo 113-8655,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2025091915085582000_ezaf291-B1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","article-title":"Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community","volume":"115","author":"Ammar","year":"2007","journal-title":"Circulation"},{"key":"2025091915085582000_ezaf291-B2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","article-title":"NAFLD and cardiovascular diseases: a clinical review","volume":"110","author":"Kasper","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"2025091915085582000_ezaf291-B3","doi-asserted-by":"crossref","first-page":"e008706","DOI":"10.1161\/CIRCHEARTFAILURE.121.008706","article-title":"Right heart failure following left ventricular device implantation: natural history, risk factors, and outcomes: an analysis of the STS INTERMACS database","volume":"15","author":"Kapelios","year":"2022","journal-title":"Circ Heart Fail"},{"key":"2025091915085582000_ezaf291-B4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.2008.03895.x","article-title":"The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B","volume":"29","author":"Mallet","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"2025091915085582000_ezaf291-B5","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.lanepe.2023.100780","article-title":"Prognostic utility of fibrosis-4 index for risk of subsequent liver and cardiovascular events, and all-cause mortality in individuals with obesity and\/or type 2 diabetes: a longitudinal cohort study","volume":"36","author":"Anstee","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"2025091915085582000_ezaf291-B6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCHEARTFAILURE.109.872556","article-title":"Clinical predictors of hepatic fibrosis in chronic advanced heart failure","volume":"3","author":"Gelow","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2025091915085582000_ezaf291-B7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1023\/B:THRO.0000011377.78585.63","article-title":"Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range","volume":"15","author":"Schmitt","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"2025091915085582000_ezaf291-B8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"2025091915085582000_ezaf291-B9","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCULATIONAHA.117.028303","article-title":"Hemocompatibility-related outcomes in the MOMENTUM 3 trial at 6 months: a randomized controlled study of a fully magnetically levitated pump in advanced heart failure","volume":"135","author":"Uriel","year":"2017","journal-title":"Circulation"},{"key":"2025091915085582000_ezaf291-B10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.1372","article-title":"Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events","volume":"21","author":"Imamura","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2025091915085582000_ezaf291-B11","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jchf.2020.09.004","article-title":"Hemocompatibility-related adverse events and survival on venoarterial extracorporeal life support: an ELSO registry analysis","volume":"8","author":"Chung","year":"2020","journal-title":"JACC Heart Fail"},{"key":"2025091915085582000_ezaf291-B12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2025091915085582000_ezaf291-B13","doi-asserted-by":"crossref","first-page":"e000598","DOI":"10.1136\/openhrt-2017-000598","article-title":"Liver stiffness assessed by fibrosis-4 index predicts mortality in patients with heart failure","volume":"4","author":"Sato","year":"2017","journal-title":"Open Heart"},{"key":"2025091915085582000_ezaf291-B14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2020.09.056","article-title":"Impact of predictive value of fibrosis-4 index in patients hospitalized for acute heart failure","volume":"324","author":"Shibata","year":"2021","journal-title":"Int J Cardiol"},{"key":"2025091915085582000_ezaf291-B15","doi-asserted-by":"crossref","first-page":"e13856","DOI":"10.1111\/eci.13856","article-title":"The fibrosis-4 score is associated with long-term mortality in different phenotypes of acute heart failure","volume":"52","author":"Tseng","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"2025091915085582000_ezaf291-B16","doi-asserted-by":"crossref","first-page":"107537","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107537","article-title":"Liver fibrosis index is associated with functional outcome among acute ischemic stroke patients","volume":"33","author":"Eto","year":"2024","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025091915085582000_ezaf291-B17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/NDT.S450061","article-title":"Relationship between liver fibrosis and increased risk of symptomatic intracranial hemorrhage in ischemic stroke patients undergoing mechanical thrombectomy","volume":"20","author":"Xu","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2025091915085582000_ezaf291-B18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12883-021-02494-0","article-title":"Liver fibrosis indices associated with substantial hematoma expansion in Chinese patients with primary intracerebral hemorrhage","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Neurol"},{"key":"2025091915085582000_ezaf291-B19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/STROKEAHA.119.028161","article-title":"Liver fibrosis indices and outcomes after primary intracerebral hemorrhage","volume":"51","author":"Parikh","year":"2020","journal-title":"Stroke"},{"key":"2025091915085582000_ezaf291-B20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.thromres.2011.07.004","article-title":"Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation","volume":"129","author":"Lind","year":"2012","journal-title":"Thromb Res"},{"key":"2025091915085582000_ezaf291-B21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCOUTCOMES.114.000804","article-title":"Improving quality measurement for anticoagulation: adding international normalized ratio variability to percent time in therapeutic range","volume":"7","author":"Razouki","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025091915085582000_ezaf291-B22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/09537104.2020.1859101","article-title":"Left ventricular assist device implantation causes platelet dysfunction and proinflammatory platelet-neutrophil interaction","volume":"33","author":"Granja","year":"2022","journal-title":"Platelets"},{"key":"2025091915085582000_ezaf291-B23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.5301\/IJAO.2011.8459","article-title":"Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device","volume":"34","author":"Slaughter","year":"2011","journal-title":"Int J Artif Organs"},{"key":"2025091915085582000_ezaf291-B24","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1002\/ehf2.14856","article-title":"Platelet count in heart failure patients undergoing left ventricular assist device","volume":"11","author":"Luo","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025091915085582000_ezaf291-B25","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1182\/blood-2015-10-636480","article-title":"Acquired von Willebrand syndrome associated with left ventricular assist device","volume":"127","author":"Nascimbene","year":"2016","journal-title":"Blood"},{"key":"2025091915085582000_ezaf291-B26","doi-asserted-by":"crossref","first-page":"1171101","DOI":"10.3389\/fnmol.2023.1171101","article-title":"Biomarkers and the outcomes of ischemic stroke","volume":"16","author":"Huang","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"2025091915085582000_ezaf291-B27","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.STR.0000244767.39962.f7","article-title":"High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability","volume":"37","author":"Bongers","year":"2006","journal-title":"Stroke"},{"key":"2025091915085582000_ezaf291-B28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MAT.0000000000002250","article-title":"Early postoperative changes in von Willebrand factor activity are associated with future bleeding and stroke in HeartMate 3 patients","volume":"71","author":"Jahangiri","year":"2025","journal-title":"ASAIO J"},{"key":"2025091915085582000_ezaf291-B29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1177\/2050640618779660","article-title":"Von Willebrand factor is a useful biomarker for liver fibrosis and prediction of hepatocellular carcinoma development in patients with hepatitis B and C","volume":"6","author":"Takaya","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"2025091915085582000_ezaf291-B30","doi-asserted-by":"crossref","first-page":"101153","DOI":"10.1016\/j.lanepe.2024.101153","article-title":"Clinical utility of the fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study","volume":"48","author":"Boeckmans","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"2025091915085582000_ezaf291-B31","doi-asserted-by":"crossref","first-page":"e039201","DOI":"10.1161\/JAHA.124.039201","article-title":"Comprehensive multiomic analysis reveals metabolic reprogramming underlying human Fontan-associated liver disease","volume":"14","author":"Sule","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2025091915085582000_ezaf291-B32","doi-asserted-by":"crossref","first-page":"oeac030","DOI":"10.1093\/ehjopen\/oeac030","article-title":"High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population","volume":"2","author":"Higashiura","year":"2022","journal-title":"Eur Heart J Open"}],"container-title":["European Journal of Cardio-Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejcts\/advance-article-pdf\/doi\/10.1093\/ejcts\/ezaf291\/64163053\/ezaf291.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/67\/9\/ezaf291\/64163053\/ezaf291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejcts\/article-pdf\/67\/9\/ezaf291\/64163053\/ezaf291.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T19:09:07Z","timestamp":1758308947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejcts\/article\/doi\/10.1093\/ejcts\/ezaf291\/8244284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ejcts\/ezaf291","relation":{},"ISSN":["1873-734X"],"issn-type":[{"type":"electronic","value":"1873-734X"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,8,29]]},"article-number":"ezaf291"}}